I think that once Mounjaro is approved for weight loss at the end of 2023 this trend will gain steam in a significant way, which would likely reflect in Q2-Q3 2024 earnings for PHG, RMD etc
GLP-1 agonists, or glucagon-like peptide-1 receptor agonists, more commonly known as GLP-1s, are a class of medications that help individuals with type 2 diabetes better regulate their glucose (blood sugar) levels
Ozempic /Wegovy : Because its designed for long-term use, weight loss builds steadily over several months, with the most significant reductions seen after a year or more
1315 For example, elevated glucose concentrations activate the transcription factor carbohydrate response element-binding protein, which indirectly promotes GLP-1 secretion through regulation of target genes in intestinal L cells
158: 13440 Herman WH
When it's flipped on, your cells shift into fat-burning mode: they increase glucose uptake in muscle, reduce the liver's glucose output, and promote fat oxidation